Webcast: Strategy of One: The Power of Integrated Provider Alerts
June 17th, 2020 at 1:00 PM ET
Pulse8 is known for enabling health plans to significantly reduce the burden placed on providers. During this challenging time, Pulse8’s latest innovation infuses Quality and Medication Adherence Alerts into their cutting-edge Collabor8™Provider Engagement Platform.This new,one-of-a-kind offering elevates Collabor8 into an integrated intervention that supports your Risk Adjustment, Quality Management, and Pharmacy programs all at once. 

Pulse8 recognizes that providers are under siege by documentation and authorizations, leaving little time for essential patient care. Duplicative tasks from various departments and/or lines of business within the health plan are the last thing busy provider offices need. Easing burden on the health plan as well, Collabor8’s new Multi-Product Dashboard delivers unparalleled analytics to prioritize, monitor, and assess the effectiveness of combined RA, QM, and Rx programs across three different lines of business – Medicare Advantage, ACA Commercial, and Managed Medicaid. 

Pulse8’s Active Intelligence™ platform furthers the efficiency by delivering user-defined Pulse Alerts – allowing the machine to work for you by providing actionable intelligence based on the KPIs that matter most to you.Provider alerts now have one point of access, one alert per member, one chart upload, and one set of dashboards to prioritize, monitor, and quantify the lift from capturing these integrated opportunities for risk adjustment, quality metrics, and medication management –a strategy of one.

During this webinar, you will learn about:

• How Pulse8’s Integrated Provider Alerts combine gaps unearthed by Calcul8 (Risk Adjustment), Qualit8 (Quality Management), and Formul8 (Medication Management) 

• How to take action on closing member-level pharmacy gaps at the point of care through Pulse8’s Collabor8 Provider Portal

• How providers and their support staff will be able to see all of these alerts in one concise, coordinated alert, and how this will yield greater efficiency at the point of care

• How to monitor program success and provider incentive programs, thereby enabling payers to determine which opportunities to present to their providers

• How this unique multi-product dashboard empowers providers and support staff to close gaps in pharmacy, in addition to quality and risk adjustment


Scott Stratton    
Vice President, Product Analytics and Chief Data Scientist

Scott Stratton is an industry leader in the design and development of products, technologies, business processes, and analytics. His focus is on collecting, integrating, organizing, mining, and modeling data to develop and optimize product development, sales, and profitability.

Scott has served as co-founder of CV-Sight, Vice President with Medco Health Solutions, Director at both Pfizer and Oxford Health Plans, and Assistant Vice President with GHI. Scott’s most significant design and development work includes Bayesian readmission analyses for one of the nation’s largest participants in CMS Innovation Center’s Bundled Payments for Care Initiative (BPCI); SAS70-compliant analytics to improve quality and costs of cardiac revascularizations; data models and processes supporting integrated pharmacy, hospital, medical, and ancillary claim data for >10 million lives, including episodes of care (ETGs) and ETG-based cost forecasting (ERGs); RightTrack™ Pfizer’s clinical trial management system still used after 13 years by the U.S. and 85 other countries for Phase II-IV trials; and co-founding Oxford’s global fees-oriented specialty management subsidiary.

Scott earned a Master’s Degree in Public Health from Yale’s School of Epidemiology and Public Health and a Bachelor of Arts in Philosophy from Carleton College. Additionally, Scott has been honored to serve on various state and national commissions, and was a founder of Yale’s John D. Thompson Fellowship Committee. CIO, American Demographics, and other periodicals have profiled him and he has published in the New England Journal of Medicine and most recently in the Journal of Clinical Oncology.

About the Sponsor

Pulse8 is a Healthcare Analytics and Technology Company delivering complete visibility into the efficacy of your Risk Adjustment, Quality, and Pharmacy Benefit Management programs. We enable health plans and providers to eliminate waste and achieve the greatest financial impact in the Medicare Advantage, Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. 
* We respect your privacy. By submitting your registration information to HealthPayerIntelligence.com  you agree to receive email communications from Xtelligent Media. Please read our Privacy Policy which contains important disclosures about how we collect and use your registration and other information. You can view our Terms of Service or you may contact us at: contactus@xtelligentmedia.com